HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross-sectional analysis

1. Kharsany AB, Karim QA. HIV infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10 : 34–48. doi: 10.2174/1874613601610010034 27347270

2. Joint United Nations Programme on HIV/AIDS. UNAIDS data 2017. Geneva: Joint United Nations Programme on HIV/AIDS; 2017 [cited 2017 Aug 24]. Available from: http://www.unaids.org/sites/default/files/media_asset/2017_data-book_en.pdf.

3. Plummer FA, Nagelkerke NJ, Moses S, Ndinya-Achola JO, Bwayo J, Ngugi E. The importance of core groups in the epidemiology and control of HIV-1 infection. AIDS. 1991;5(Suppl 1):S169–76.

4. Hunter DJ. AIDS in sub-Saharan Africa: the epidemiology of heterosexual transmission and the prospects for prevention. Epidemiology. 1993;4(1):63–72. 8420583

5. Delva W, Abdool Karim Q. The HIV epidemic in Southern Africa—is an AIDS-free generation possible? Curr HIV/AIDS Rep. 2014;11(2):99–108. doi: 10.1007/s11904-014-0205-0 24676559

6. Baral SD, Grosso A, Holland C, Papworth E. The epidemiology of HIV among men who have sex with men in countries with generalized HIV epidemics. Curr Opin HIV AIDS. 2014;9(2):156–67. doi: 10.1097/COH.0000000000000037 24445371

7. Djomand G, Quaye S, Sullivan PS. HIV epidemic among key populations in west Africa. Curr Opin HIV AIDS. 2014;9(5):506–13. doi: 10.1097/COH.0000000000000090 25010898

8. Baral SD, Ketende S, Mnisi Z, Mabuza X, Grosso A, Sithole B, et al. A cross-sectional assessment of the burden of HIV and associated individual -⁠ and structural-level characteristics among men who have sex with men in Swaziland. J Int AIDS Soc. 2013;16(Suppl 3):18768. doi: 10.7448/ias.16.4.18768 24321117

9. Wirtz AL, Trapence G, Kamba D, Gama V, Chalera R, Jumbe V, et al. Geographical disparities in HIV prevalence and care among men who have sex with men in Malawi: results from a multisite cross-sectional survey. Lancet HIV. 2017;4(6):e260–9. doi: 10.1016/S2352-3018(17)30042-5 28256422

10. Jobson GA, Theron LB, Kaggwa JK, Kim H-J. Transgender in Africa: invisible, inaccessible, or ignored? SAHARA J. 2012;9(3):160–3. doi: 10.1080/17290376.2012.743829 23237071

11. Evans MGB, Cloete A, Zungu N, Simbayi LC. HIV risk among men who have sex with men, women who have sex with women, lesbian, gay, bisexual and transgender populations in South Africa: a mini-review. Open AIDS J. 2016;10 : 49–64. doi: 10.2174/1874613601610010049 27347271

12. Poteat T, Scheim A, Xavier J, Reisner S, Baral S. Global epidemiology of HIV infection and related syndemics affecting transgender people. J Acquir Immune Defic Syndr. 2016;72(Suppl 3):S210–9. doi: 10.1097/qai.0000000000001087 27429185

13. Poteat T, German D, Flynn C. The conflation of gender and sex: gaps and opportunities in HIV data among transgender women and MSM. Glob Public Health. 2016;11(7–8):835–48. doi: 10.1080/17441692.2015.1134615 26785751

14. Baral SD, Poteat T, Strömdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22. doi: 10.1016/S1473-3099(12)70315-8 23260128

15. Joint United Nations Programme on HIV/AIDS. Indicators: transgender people—HIV prevalence in transgender people. Geneva: Joint United Nations Programme on HIV/AIDS; 2016 [cited 2017 Aug 24]. Available from: http://aidsinfo.unaids.org/.

16. Joint United Nations Programme on HIV/AIDS. Factsheets: country fact sheets—Democratic Republic of the Congo. Geneva: Joint United Nations Programme on HIV/AIDS; 2016 [cited 2017 Aug 24]. Available from: http://aidsinfo.unaids.org/.

17. Stahlman S, Liestman B, Ketende S, Kouanda S, Ky-Zerbo O, Lougue M, et al. Characterizing the HIV risks and potential pathways to HIV infection among transgender women in Cote d’Ivoire, Togo and Burkina Faso. J Int AIDS Soc. 2016;19(3 Suppl 2):20774. doi: 10.7448/IAS.19.3.20774 27431465

18. Heckathorn DD. Snowball versus respondent-driven sampling. ‎Sociol Methodol. 2011;41(1):355–66. doi: 10.1111/j.1467-9531.2011.01244.x 22228916

19. Mason K, Ketende S, Peitzmeier S, Ceesay N, Diouf D, Loum J, et al. A cross-sectional analysis of population demographics, HIV knowledge and risk behaviors, and prevalence and associations of HIV among men who have sex with men in the Gambia. AIDS Res Hum Retroviruses. 2013;29(12):1547–52. doi: 10.1089/AID.2013.0092 23875674

20. Mbachu II, Udigwe G, Joseph I, John O, Samuel UO, Joseph U, et al. The evaluation of accuracy of serial rapid HIV test algorithm in the diagnosis of HIV antibodies among pregnant women in south east Nigeria. BMC Res Notes. 2015;8 : 557. doi: 10.1186/s13104-015-1454-8 26459010

21. Winter S, Diamond M, Green J, Karasic D, Reed T, Whittle S, et al. Transgender people: health at the margins of society. Lancet. 2016;388(10042):390–400. doi: 10.1016/S0140-6736(16)00683-8 27323925

22. Stahlman S, Sanchez TH, Sullivan PS, Ketende S, Lyons C, Charurat ME, et al. The prevalence of sexual behavior stigma affecting gay men and other men who have sex with men across sub-Saharan Africa and in the United States. JMIR Public Health Surveill. 2016;2(2):e35. doi: 10.2196/publichealth.5824 27460627

23. R Core Team. R: A language and environment for statistical computing Vienna: R Foundation for Statistical Computing; 2016 [cited 2017 Oct 3]. Available from: http://www.R-project.org.

24. Flora DB, Flake JK. The purpose and practice of exploratory and confirmatory factor analysis in psychological research: decisions for scale development and validation. ‎Can J Behav Sci. 2017;49(2):78–88. doi: 10.1037/cbs0000069

25. Wong GY, Mason WM. The hierarchical logistic regression model for multilevel analysis. J Am Stat Assoc. 1985;80(391):513–24. doi: 10.1080/01621459.1985.10478148

26. Murray SO, Roscoe W. Boy-wives and female-husbands: studies in African homosexualities. New York: St. Martin’s Press; 1998.

27. Morgan R, Marais C, Wellbeloved JR. Trans: transgender life stories from South Africa. Sister Namibia. 2009;21(4–5):32–3.

28. Transgender and Intersex Africa. 2017 [cited 2017 May 30]. Available from: http://transgenderintersexafrica.org.za/.

29. Astraea Lesbian Foundation for Justice. S.H.E, Social, Health and Empowerment Feminist Collective of Transgender Women of Africa. New York: Astraea Lesbian Foundation for Justice; 2017 [cited 2017 Oct 7]. Available from: https://www.astraeafoundation.org/stories/s-h-e-social-health-and-empowerment-feminist-collective-of-transgender-women-of-africa/.

30. The People’s Matrix Association. 2017 [cited 2017 May 30]. Available from: https://www.facebook.com/The-Peoples-Matrix-Association-294891844889/.

31. Migiro K. Meet one of Africa’s transgender pioneers. Los Angeles: TakePart; 2015 Apr 14 [cited 2017 May 30]. Available from: http://www.takepart.com/article/2015/04/14/meet-one-africas-transgender-warriors.

32. The Pearl of Africa. 2017 [cited 2017 May 30]. Available from: http://pearlofafrica.tv/.

33. Grubb IR, Beckham SW, Kazatchkine M, Thomas RM, Albers ER, Cabral M, et al. Maximizing the benefits of antiretroviral therapy for key affected populations. J Int AIDS Soc. 2014;17 : 19320. doi: 10.7448/IAS.17.1.19320 25043380

34. Joint United Nations Programme on HIV/AIDS. Fact sheets: country fact sheets—Lesotho. Geneva: Joint United Nations Programme on HIV/AIDS; 2016 [cited 2017 Aug 24]. Available from: http://aidsinfo.unaids.org/.

35. Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014;28(10):1509–19. doi: 10.1097/QAD.0000000000000298 24809629

36. Baggaley RF, White RG, Boily M -⁠ C. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. ‎Int J Epidemiol. 2010;39(4):1048–63. doi: 10.1093/ije/dyq057 20406794

37. Martins TA, Kerr LR, Macena RH, Mota RS, Carneiro KL, Gondim RC, et al. Travestis, an unexplored population at risk of HIV in a large metropolis of northeast Brazil: a respondent-driven sampling survey. AIDS Care. 2013;25(5):606–12. doi: 10.1080/09540121.2012.726342 23082818

38. Guadamuz TE, Wimonsate W, Varangrat A, Phanuphak P, Jommaroeng R, McNicholl JM, et al. HIV prevalence, risk behavior, hormone use and surgical history among transgender persons in Thailand. AIDS Behav. 2011;15(3):650–8. doi: 10.1007/s10461-010-9850-5 21104008

39. Santos GM, Rapues J, Wilson EC, Macias O, Packer T, Colfax G, et al. Alcohol and substance use among transgender women in San Francisco: prevalence and association with human immunodeficiency virus infection. Drug Alcohol Rev. 2014;33(3):287–95. doi: 10.1111/dar.12116 24628655

40. Secor AM, Wahome E, Micheni M, Rao D, Simoni JM, Sanders EJ, et al. Depression, substance abuse and stigma among men who have sex with men in coastal Kenya. AIDS. 2015;29(Suppl 3):S251–9. doi: 10.1097/qad.0000000000000846 26562814

41. Lane T, Raymond HF, Dladla S, Rasethe J, Struthers H, McFarland W, et al. High HIV prevalence among men who have sex with men in Soweto, South Africa: results from the Soweto Men’s Study. AIDS Behav. 2011;15(3):626–34. doi: 10.1007/s10461-009-9598-y 19662523

42. Johnston LG, Holman A, Dahoma M, Miller LA, Kim E, Mussa M, et al. HIV risk and the overlap of injecting drug use and high-risk sexual behaviours among men who have sex with men in Zanzibar (Unguja), Tanzania. Int J Drug Policy. 2010;21(6):485–92. doi: 10.1016/j.drugpo.2010.06.001 20638262

43. Joint United Nations Programme on HIV/AIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2014.

44. Joint United Nations Programme on HIV/AIDS. On the fast-track to end AIDS: UNAIDS 2016–2021 Strategy. Geneva: Joint United Nations Programme on HIV/AIDS; 2015.

45. World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations—2016 update. Geneva: World Health Organization; 2016.

46. Stevens DR, Vrana CJ, Dlin RE, Korte JE. A global review of HIV self-testing: themes and implications. AIDS Behav. 2017 Feb 2. doi: 10.1007/s10461-017-1707-8 28155039

47. Ippoliti NB, L’Engle K. Meet us on the phone: mobile phone programs for adolescent sexual and reproductive health in low-to-middle income countries. Reprod Health. 2017;14(1):11. doi: 10.1186/s12978-016-0276-z 28095855

48. Nyaku AN, Kelly SG, Taiwo BO. Long-acting antiretrovirals: where are we now? Curr HIV/AIDS Rep. 2017;14(2):63–71. doi: 10.1007/s11904-017-0353-0 28303548

49. Chibanda D. Depression and HIV: integrated care towards 90-90-90. Int Health. 2017;9(2):77–9. doi: 10.1093/inthealth/ihw058 28115469

50. Mayer KH, Grinsztejn B, El-Sadr WM. Transgender people and HIV prevention: what we know and what we need to know, a call to action. J Acquir Immune Defic Syndr. 2016;72(Suppl 3):S207–9. doi: 10.1097/qai.0000000000001086 27429184

51. Sevelius JM. Gender affirmation: a framework for conceptualizing risk behavior among transgender women of color. Sex Roles. 2013;68(11–12):675–89. doi: 10.1007/s11199-012-0216-5 23729971

52. Grant RM, Sevelius JM, Guanira JV, Aguilar JV, Chariyalertsak S, Deutsch MB. Transgender women in clinical trials of pre-exposure prophylaxis. J Acquir Immune Defic Syndr. 2016;72(Suppl 3):S226–9. doi: 10.1097/qai.0000000000001090 27429187

53. Reisner SL, Radix A, Deutsch MB. Integrated and gender-affirming transgender clinical care and research. J Acquir Immune Defic Syndr. 2016;72(Suppl 3):S235–42. doi: 10.1097/qai.0000000000001088 27429189

54. Sevelius JM, Keatley J, Calma N, Arnold E. ‘I am not a man’: trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016;11(7–8):1060–75. doi: 10.1080/17441692.2016.1154085 26963756

55. Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015;2(12):e512–9. doi: 10.1016/S2352-3018(15)00206-4 26614965

56. Anderson PL, Reirden D, Castillo-Mancilla J. Pharmacologic considerations for preexposure prophylaxis in transgender women. J Acquir Immune Defic Syndr. 2016;72(Suppl 3):S230–4. doi: 10.1097/qai.0000000000001105 27429188

57. Eckstrand KL, Potter J. Trauma, resilience, and health promotion in LGBT patients: what every healthcare provider should know. New York: Springer; 2017.

58. Sales JM, Swartzendruber A, Phillips AL. Trauma-informed HIV prevention and treatment. Curr HIV/AIDS Rep. 2016;13(6):374–82. doi: 10.1007/s11904-016-0337-5 27704251

59. Wolf RC, Adams D, Dayton R, Verster A, Wong J, Romero M, et al. Putting the t in tools: a roadmap for implementation of new global and regional transgender guidance. J Int AIDS Soc. 2016;19(Suppl 2):20801.

60. Deutsch MB, Feldman JL. Updated recommendations from the World Professional Association for Transgender Health standards of care. Am Fam Phys2013;87(2):89–93.

61. Chakrapani V, Vijin PP, Logie CH, Newman PA, Shunmugam M, Sivasubramanian M, et al. Understanding how sexual and gender minority stigmas influence depression among trans women and men who have sex with men in India. LGBT Health. 2017;4(3):217–26. doi: 10.1089/lgbt.2016.0082 28422615

62. Stahlman S, Hargreaves JR, Sprague L, Stangl AL, Baral SD. Measuring sexual behavior stigma to inform effective HIV prevention and treatment programs for key populations. JMIR Public Health Surveill. 2017;3(2):e23. doi: 10.2196/publichealth.7334 28446420

63. Thapa S, Hannes K, Cargo M, Buve A, Aro AR, Mathei C. Building a conceptual framework to study the effect of HIV stigma-reduction intervention strategies on hiv test uptake: a scoping review. J Assoc Nurses AIDS Care. 2017;28(4):545–60. doi: 10.1016/j.jana.2017.04.004 28473183

64. Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? J Int AIDS Soc. 2013;16(3 Suppl 2):18734. doi: 10.7448/IAS.16.3.18734 24242268